Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.
暂无分享,去创建一个
H. Deeg | E. Guinan | B. George | R. Gale | M. Thakar | M. MacMillan | S. Davies | Richard E. Harris | M. Ayas | G. Socié | E. Copelan | P. Stepensky | A. Fasth | B. Camitta | B. Wirk | M. Battiwalla | R. Olsson | W. Saber | R. Bajwa | G. Hale | S. Slavin | B. Horn | R. Pasquini | M. Bierings | C. Bonfim | V. Lewis | A. Al-Seraihy | Jennifer Lerademacher | A. Al Jefri | R. Harris
[1] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[2] S. Revel-Vilk,et al. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] F. Sigaux,et al. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. , 2011, Blood.
[4] T. Smolarek,et al. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia. , 2010, Cancer genetics and cytogenetics.
[5] I. Dokal. Inherited bone marrow failure syndromes , 2011 .
[6] J. Wagner,et al. Haematopoeitic cell transplantation for Fanconi anaemia – when and how? , 2010, British journal of haematology.
[7] J. Wagner,et al. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics. , 2010, American journal of clinical pathology.
[8] David A. Williams,et al. Finding the needle in the hay stack: hematopoietic stem cells in Fanconi anemia. , 2009, Mutation research.
[9] M. Freedman,et al. Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation , 2009, Pediatric blood & cancer.
[10] A. Barrett,et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. , 2009, Blood.
[11] J. Soulier,et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation , 2008, Cancer.
[12] J. Wagner,et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] M. Ayas,et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience , 2008, Bone Marrow Transplantation.
[14] M. Ayas,et al. Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] P. Rosenberg,et al. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry , 2008, Haematologica.
[16] I. Dokal. Fanconi anemia is a highly penetrant cancer susceptibility syndrome. , 2008, Haematologica.
[17] M. Ayas,et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience , 2008, Bone Marrow Transplantation.
[18] J. Klein,et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] J. Wagner,et al. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome , 2008, Bone Marrow Transplantation.
[20] R. Storb,et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[21] A. Pession,et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group , 2007, Haematologica.
[22] J. Wagner,et al. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] J. Wagner,et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. , 2007, Blood.
[24] A. Auerbach,et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience , 2007, British journal of haematology.
[25] P. Greenberg,et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. , 2006, The New England journal of medicine.
[26] S. Elad,et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[27] J. Wagner,et al. Successful engraftment without radiation after fludarabine‐based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation , 2006, Pediatric blood & cancer.
[28] John M Bennett,et al. Decitabine improves patient outcomes in myelodysplastic syndromes , 2006, Cancer.
[29] A. D’Andrea,et al. The Fanconi Anemia/BRCA pathway: new faces in the crowd. , 2005, Genes & development.
[30] H. Deeg,et al. Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia , 2005, British journal of haematology.
[31] A. Bosi,et al. Allogeneic stem cell transplantation. , 2005, Transplantation proceedings.
[32] M. Ayas,et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy , 2005, Bone Marrow Transplantation.
[33] B. George,et al. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia , 2005, Bone Marrow Transplantation.
[34] John P Klein,et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. , 2004, Blood.
[35] M. Tischkowitz,et al. Fanconi anaemia and leukaemia – clinical and molecular aspects , 2004, British journal of haematology.
[36] Alan D. D'Andrea. Fanconi anemia , 2003, Current Biology.
[37] W. Ebell,et al. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. , 2003, Blood.
[38] Marianne Berwick,et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.
[39] P. Rosenberg,et al. Cancer incidence in persons with Fanconi anemia. , 2003, Blood.
[40] H. Lazarus,et al. Allogeneic Stem Cell Transplantation , 2002, Current Clinical Oncology.
[41] H. Deeg,et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. , 2002, Blood.
[42] J. Holland,et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] B. Alter,et al. Fanconi anemia: myelodysplasia as a predictor of outcome. , 2000, Cancer genetics and cytogenetics.
[44] H. Deeg,et al. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. , 2000, Blood.
[45] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[46] H. Esperou,et al. Transplantation for Fanconi's anaemia: long‐term follow‐up of fifty patients transplanted from a sibling donor after low‐dose cyclophosphamide and thoraco‐abdominal irradiation for conditioning , 1998, British journal of haematology.
[47] A. Nagler,et al. A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemia , 1997, Bone Marrow Transplantation.
[48] J. Klein,et al. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.
[49] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[50] R. Berger,et al. Faconi anemia and bone marrow clonal chromosome abnormalities. , 1996, Leukemia.
[51] H. Deeg,et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. , 1996, Blood.
[52] S. Kato,et al. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia. , 1995, Bone marrow transplantation.
[53] B. Alter. Hematologic abnormalities in Fanconi anemia. , 1995, Blood.
[54] R. Gale,et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. , 1994, Blood.
[55] E. Gordon-Smith,et al. Successful bone marrow transplant for Fanconi anaemia in transformation. , 1994, Bone marrow transplantation.
[56] V. Najfeld,et al. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? , 1993, British journal of haematology.
[57] R. G. Allen,et al. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. , 1991, Cancer genetics and cytogenetics.
[58] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.